EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MiR-145-5p modulates collagen production and fibroblast behaviour after cardiac injury partially via COL5A1

Hong Wang, Jere Paavola, Sanni Perttunen, Katariina Immonen, Ian Hägerström, Suneeta Narumanchi, Karri Kalervo, Johanna Tolva, Juha Sinisalo, Mikko I Mäyränpää, Heikki Ruskoaho, Riikka Kosonen und 4 weitere

Basic Research in Cardiology · 2026

DOI: 10.1007/s00395-026-01199-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Basic Research in Cardiology, 2026. Verfasst von Hong Wang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Minerva Foundation Institute for Medical Research, Biomedicum Helsinki 2U, Tukholmankatu 8, 00290, Helsinki, Finland. hong.wang@helsinki.fi. Hauptthemen laut MEDLINE: MicroRNAs, Fibroblasts, Collagen Type V, Heart Injuries. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Suomen Kulttuurirahasto, Sydäntutkimussäätiö, Aarne Koskelon Säätiö.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In contrast to humans, zebrafish hearts after cryoinjury undergo transient fibrotic scarring that subsequently resolves and renews with functional cardiomyocytes. To understand the molecular mechanisms underlying cardiac scarring and fibrotic resolution in zebrafish, we investigated cardiac transcriptomic responses in zebrafish at 14 days post-cryoinjury. Principal component analyses revealed distinct transcriptome clusters corresponding to healthy and injured hearts, highlighting significant changes during cardiac regeneration. Gene set enrichment analyses indicated that extracellular matrix organization and inflammatory response pathways were activated in cryoinjured hearts, while mitochondrial organization and oxidative phosphorylation pathways were downregulated. Notably, miR-145-5p was downregulated and col5a1 upregulated in the cryoinjured hearts, contrasting with the expression patterns of miR-145-5p and COL5α1 in the left ventricles of ischemic cardiomyopathy patients. Prediction of miRNA-mRNA interaction and a dual luciferase assay identified COL5A1 as a target of miR-145-5p. Inhibition of miR-145-5p in human cardiac fibroblasts increased COL5A1 and α-SMA, decreased COL1A, and stimulated fibroblast differentiation, proliferation, and migration. Conversely, overexpression of miR-145-5p led to the opposite effects. Downregulation of COL5A1 suppressed fibroblast proliferation and migration, which could be rescued by inhibition of miR-145-5p. Moreover, downregulation of col5a1 attenuated cardiac fibrotic scar resolution in zebrafish. Interestingly, downregulation of COL5A1 or inhibition of miR-145-5p diminished the expression of integrin subunits ITGβ3 and ITGβ5. Furthermore, inhibition of miR-145-5p potentiated the suppression of TGF-β/SMAD signalling and the enhancement of fibroblast proliferation mediated by inhibiting integrin αvβ3 and αvβ5 with cilengitide. Collectively, miR-145-5p modulates collagen production and fibroblast behaviour partially via targeting COL5A1 and through integrin-mediated pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsFibroblastsCollagen Type VHeart InjuriesZebrafish ProteinsMyocardiumCollagenAnimalsZebrafishHumansFibrosisCell ProliferationDisease Models, AnimalSignal TransductionCells, CulturedCell Movement

Stichwörter der Autor:innen

COL5A1Cardiac fibrosisCardiac scar resolutionMiR-145-5p

Substanzen

MicroRNAsCollagen Type VMIRN145 microRNA, humanCOL5A1 protein, humanZebrafish ProteinsCollagen

Autor:innen und Institutionen

  • Minerva Foundation Institute for Medical Research, Biomedicum Helsinki 2U, Tukholmankatu 8, 00290, Helsinki, Finland. hong.wang@helsinki.fi.
  • Minerva Foundation Institute for Medical Research, Biomedicum Helsinki 2U, Tukholmankatu 8, 00290, Helsinki, Finland.
  • Heart and Lung Centre, University of Helsinki and Helsinki University Hospital, 00014, Helsinki, Finland.
  • Abdominal Centre Gastrointestinal Surgery, University of Helsinki and Helsinki University Hospital, 00014, Helsinki, Finland.
  • Department of Pathology, University of Helsinki and Helsinki University Hospital, 00014, Helsinki, Finland.
  • Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, 00014, Helsinki, Finland.

Förderung

  • Suomen Kulttuurirahasto
  • Sydäntutkimussäätiö
  • Aarne Koskelon Säätiö
  • the Finnish Foundation for Laboratory Medicine
  • Finska Läkaresällskapet
  • Medicinska Understödsföreningen Liv och Hälsa
  • Sigrid Juséliuksen Säätiö
  • Finnish state funding for university-level research

Zitieren

APA

Wang, H., Paavola, J., Perttunen, S., Immonen, K., Hägerström, I., Narumanchi, S., Kalervo, K., Tolva, J., Sinisalo, J., Mäyränpää, M. I., Ruskoaho, H., Kosonen, R., Olkkonen, V. M., Laine, M., Tikkanen, I., & Lakkisto, P. (2026). MiR-145-5p modulates collagen production and fibroblast behaviour after cardiac injury partially via COL5A1. Basic Research in Cardiology. https://doi.org/10.1007/s00395-026-01199-0

Vancouver

Wang H, Paavola J, Perttunen S, Immonen K, Hägerström I, Narumanchi S, et al. MiR-145-5p modulates collagen production and fibroblast behaviour after cardiac injury partially via COL5A1. Basic Research in Cardiology. 2026. doi:10.1007/s00395-026-01199-0

BibTeX
@article{Wang2026,
  author = {Wang, Hong and Paavola, Jere and Perttunen, Sanni and Immonen, Katariina and Hägerström, Ian and Narumanchi, Suneeta and Kalervo, Karri and Tolva, Johanna and Sinisalo, Juha and Mäyränpää, Mikko I and Ruskoaho, Heikki and Kosonen, Riikka and Olkkonen, Vesa M and Laine, Mika and Tikkanen, Ilkka and Lakkisto, Päivi},
  title = {MiR-145-5p modulates collagen production and fibroblast behaviour after cardiac injury partially via COL5A1},
  journal = {Basic Research in Cardiology},
  year = {2026},
  doi = {10.1007/s00395-026-01199-0}
}
Kostenlos starten →